INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

21,218 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$22K
988 sh
Aug 5, 2026Aug 13, 2026
Page 195 of 531
← PrevNext →
traded Aug 5, 2026
+8d
SEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$26K
1,163 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$34K
1,556 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$2,211
100 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
CE
Childers Jason E.SVP, Information Technology
WRLDWORLD ACCEPTANCE CORP
Open-market sale
SELL$381K
2,000 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

31
KJ
Kuai JeffGeneral Manager, Pizza Hut
YUMCYum China Holdings, Inc.
Open-market sale
SELL$253K
5,313 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$23K
1,040 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$2,199
100 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$29K
1,332 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$9,776
447 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
RENAISSANCE TECHNOLOGIES LLC13F filer
VVISA INC.
TRIM
SELL$189.91M
553.5K sh
Not disclosedAug 13, 2026quarterlySEC 13F

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$17K
753 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$15K
672 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

29
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$284K
3,120 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

29
LG
Lucas Stephen GSVP, Culture and Engagement
KOPKoppers Holdings Inc.
Open-market sale
SELL$58K
1,308 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

29
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$605K
3,704 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

28
AA
Ahmed AsmauDirector
QNSTQUINSTREET, INC
Open-market sale
SELL$104K
5,000 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

28
KJ
Kuai JeffGeneral Manager, Pizza Hut
YUMCYum China Holdings, Inc.
Open-market sale
SELL$237K
4,961 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

28
BL
Byers Deborah LDirector
KNTKKinetik Holdings Inc.
Open-market sale
SELL$141K
2,739 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

28
KJ
Kuai JeffGeneral Manager, Pizza Hut
YUMCYum China Holdings, Inc.
Open-market sale
SELL$206K
4,312 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

27
MP
McCarthy Cornelius P. IIIDirector
MEDPMedpace Holdings, Inc.
Open-market sale
SELL$690K
1,140 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

26
KV
Kuzoyan VaheDirector, President
TTANServiceTitan, Inc.
Open-market sale · 10b5-1 plan
SELL$4.39M
49.4K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$55K
585 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$77K
845 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

24
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale
SELL$220K
8,300 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

24
BP
Burnett PatrickSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale
SELL$175K
6,700 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

24
AA
Ahmed AsmauDirector
QNSTQUINSTREET, INC
Open-market sale
SELL$204K
10.0K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

23
KV
Kuzoyan VaheDirector, President
TTANServiceTitan, Inc.
Open-market sale · 10b5-1 plan
SELL$259K
2,913 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

23
CJ
Colgrove JohnDirector, Chief Visionary Officer
PEverpure, Inc.
Open-market sale · 10b5-1 plan
SELL$997K
9,129 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

22
CJ
Colgrove JohnDirector, Chief Visionary Officer
PEverpure, Inc.
Open-market sale · 10b5-1 plan
SELL$2.33M
22.4K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

22
CJ
Colgrove JohnDirector, Chief Visionary Officer
PEverpure, Inc.
Open-market sale · 10b5-1 plan
SELL$2.18M
21.1K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

22
KV
Kuzoyan VaheDirector, President
TTANServiceTitan, Inc.
Open-market sale · 10b5-1 plan
SELL$3.15M
35.4K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

22
SH
Shah HusnalChief Product Officer
FNKOFunko, Inc.
Open-market sale
SELL$1,201
200 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

22
CJ
Colgrove JohnDirector, Chief Visionary Officer
PEverpure, Inc.
Open-market sale · 10b5-1 plan
SELL$1.00M
9,459 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

22
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$67K
400 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

21
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$960K
2,666 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

21
EA
Elsztain Fernando AdrianDirector
CRESYCRESUD INC
Open-market sale
SELL$11K
10.0K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

20
SO
Schuth Alexander O.COFO and Secretary
DNLIDenali Therapeutics Inc.
Open-market sale
SELL$72K
2,857 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

19
HR
Howard Justyn RussellDirector, Executive Chair, 10% Owner
SPTSprout Social, Inc.
Open-market sale · 10b5-1 plan
SELL$405K
40.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

19
CJ
Colgrove JohnDirector, Chief Visionary Officer
PEverpure, Inc.
Open-market sale · 10b5-1 plan
SELL$606K
5,597 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence